Dear Сolleagues! Pocard Ltd. invites you to join the Webinar Therapeutic apheresis in ABO-incompatible transplantations. The webinar will take part at 2:00-3:30 PM (UTC+3) on November 12. Program 1. Introduction to the problem (5 min) Bernhard Schmidt, Prof., MD, M.Sc. (Clin Epi.), Hannover Medical School, Hannover, Germany, 2. Experience of ABO-incompatible kidney transplantation from
Double filtration plasmapheresis (DFPP)
Selective Plasma Exchange
ASFA Guidelines on the Use of Therapeutic Apheresis in Clinical Practice, 2019
Webinar "Therapeutic apheresis in ABO-incompatible transplantations", 12.11.2020
1. Dr. Arzumanov. Experience of ABO-incompatible kidney transplantation from a living related donor.
2. Prof. Schmidt. Apheresis in AB0-Incompatible Renal Transplantation.
3. Dr. Adamova. Pocard Ltd. presentation
Toxipak is now CE certified! Pocard Ltd. received the CE mark approval for the Toxipak® columns! Toxipak® adsorption column is designed for the procedures of LPS adsorption — selective hemoperfusion of endotoxin (lipopolysaccharide) of Gram-negative bacteria in treatment of sepsis and septic shock. The Toxipak® columns are released in plastic cases
Therapeutic Apheresis for Management of Lp(a) Hyperlipoproteinemia Elevated lipoprotein(a) (Lp(a)) is recognized as an independent cardiovascular risk factor with prevalence of about 20% in general population and much higher prevalence among subjects with atherosclerotic cardiovascular disease (ASCVD) [Nordestgaard BG, 2010]. Specific Lp(a) apheresis is the only possible method that solely